Azilect
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Introduction: Parkinson‟s disease (PD) is characterized by a chronic progressive loss of nigrostriatal dopaminergic neurons that…
Background—Despite the availability of many pharmacological and mechanical therapies, the mortality rate among patients with…
A long-term, follow-up study on Parkinson's disease drug rasagiline (Azilect) showed that it can slow disease progression if…
Rasaligine (Azilect) is a new MAO‐B inhibitor for use in Parkinson's disease as monotherapy or as an adjunct, offering a once…